CataractNCT07468409
JASPER™ Robotic Surgical System (Formerly Known as the ORYOM™ Robotic Surgical System) in Cataract Surgery
A study testing JASPER™ Robotic Surgical System in people with Cataract, run by ForSight Robotics Ltd at 1 site in Philippines.
Trial summary
This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery. Read more about this study
- Who is it for?
- Ages 55 to 80 years
- Conditions the study is for
- Cataract
- What is being tested?
- JASPER™ Robotic Surgical System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 sitePhilippines
- Study dates
- 20 Feb 2026to Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Main Inclusion Criteria:
- Patient aged 55 to 80 years
- Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol
- Patients are scheduled to undergo cataract surgery
- Clear intraocular media, other than cataract
- Pupil dilate according to stand of care
Main Exclusion Criteria:
- Prior ocular surgery or trauma in the study eye
- Polar cataract in the study eye
- Zonular instability or significant anterior segment abnormalities
- Active ocular infection or uveitis
- Pseudoexfoliation (PXF) syndrome in either eye
- ASA Physical Status Classification > 3
- Participation in another clinical trial within 30 days
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Philippines1 site, 1 recruiting
- Recruiting
Asian Eye Instiitute
Makati City, National Capital Region, 1200
Robert Ang, Dr., (02) 8-898-2020, eyehelp@asianeyeinstitute.com
About this study
Official title: Single-site, Open-label, Prospective Feasibility Study Performed Using the JASPER™ Robotic Surgical System in Cataract Surgery Procedures
This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery.
- Conditions
- Cataract
- Being tested
- JASPER™ Robotic Surgical System
- Medical subject headings
- Cataract
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
JASPER™ Robotic Surgical SystemDevice
The JASPER™ Robotic Surgical System is a robotically assisted surgical system intended to assist ophthalmic surgeons in performing cataract surgery.
| Study group | Role | What they receive |
|---|---|---|
| JASPER™ Robotic Surgical System | Experimental | Subjects will undergo cataract surgery using the JASPER™ Robotic Surgical System. Receives: Device: JASPER™ Robotic Surgical System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Successful completion of planned Robotic-Assisted cataract surgery
Proportion of study eyes in which the planned robotic cataract surgery is completed using the JASPER™ Robotic Surgical System without conversion to manual technique.
Measured: Intra-operative
Secondary outcomes (3)
Incidence and Type of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Incidence and type of all AEs and SAEs occurring intraoperatively and during the postoperative follow-up period.
Measured: From surgery through 30 days post-procedure
Distribution of pre and postoperative Best Corrected Visual acuity
Distribution of preoperative and postoperative BCVA
Measured: Baseline and up to 30 days post-procedure
Postoperative Ophthalmic examination findings
Postoperative slit lamp and dilated fundus examinations findings
Measured: Up to 30 days post-procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2026
- Study start20 Feb 2026
- Primary completionFeb 2027 (estimated)
- Study completionApr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CataractStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- ForSight Robotics Ltd
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07468409
- Sponsor's protocol ID
- CPH000003
- Status last verified
- Jul 2026
- First submitted
- 5 Mar 2026
- Last updated
- 24 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared at this time due to privacy, confidentiality, and regulatory considerations. Future sharing may be considered under appropriate agreements and conditions.
Study at a glance
From the registry record, last updated by the sponsor on 24 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Single-site, Open-label, Prospective Feasibility Study Performed Using the JASPER™ Robotic Surgical System in Cataract Surgery Procedures
- ClinicalTrials.gov ID
- NCT07468409
- Acronym / sponsor ID
- CPH000003
- Conditions
- Cataract
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- ForSight Robotics LtdIndustry (pharma, biotech, devices)
- Study start
- 20 Feb 2026 (actual)
- Primary completion
- Feb 2027 (estimated)
- Study completion
- Apr 2027 (estimated)
- First posted
- 12 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| JASPER™ Robotic Surgical System | Experimental | Device: JASPER™ Robotic Surgical SystemSubjects will undergo cataract surgery using the JASPER™ Robotic Surgical System. |
Who may qualify
- Ages
- 55 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| JASPER™ Robotic Surgical SystemThe JASPER™ Robotic Surgical System is a robotically assisted surgical system intended to assist ophthalmic surgeons in performing cataract surgery. | Device | JASPER™ Robotic Surgical System |
Primary outcome
Successful completion of planned Robotic-Assisted cataract surgery
Time frame: Intra-operative
Proportion of study eyes in which the planned robotic cataract surgery is completed using the JASPER™ Robotic Surgical System without conversion to manual technique.
3 secondary outcomes
Incidence and Type of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Time frame: From surgery through 30 days post-procedure
Distribution of pre and postoperative Best Corrected Visual acuity
Time frame: Baseline and up to 30 days post-procedure
Postoperative Ophthalmic examination findings
Time frame: Up to 30 days post-procedure
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jul 2026.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared at this time due to privacy, confidentiality, and regulatory considerations. Future sharing may be considered under appropriate agreements and conditions.
Related trials for Cataract
Recruiting
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Glaucoma, Ocular Hypertension
Not yet recruiting
Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction of Aphakia Following Cataract Extraction
Aphakia, Postcataract
Not yet recruiting
Effects of Oxygen Cage Support During Cataract Surgery
Cataract
Active, not recruitingObservational study
Age-Related Eye Disease Study (AREDS) Follow-Up
Age-Related Macular Degeneration, Cataract
RecruitingObservational study
Objective Depth-of-Focus Changes During Light Adjustable Lens UV Adjustments
Light Adjustable Lens, Objective Depth of Focus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing JASPER™ Robotic Surgical System in people with Cataract, run by ForSight Robotics Ltd at 1 site in Philippines.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Philippines. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Merav Gat, M.Sc., MBA (+972547800259, merav.gat@forsightrobotics.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Successful completion of planned Robotic-Assisted cataract surgery (time frame: Intra-operative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2026.